Monday, October 28, 2013

Viva La Evidence

›
We came across this brilliant music video   “ Viva La Evidence ” by Dr. James McCormack. It’s a parody of Coldplay's Viva La Vida and th...
Sunday, October 20, 2013

Venlafaxine Pathway published in PG&G

›
Venlafaxine is a s erotonin-norepinephrine reuptake inhibitor (SNRI) marketed for the treatment of depression disorders. We recen...
Thursday, October 17, 2013

NIH funds ClinGen: a resource to establish which genetic variants are clinically relevant

›
The NIH ( NHGRI and NICHD ) has awarded more than $25 million over the course of 4 years for the development of the Clinical Genom...
Tuesday, October 15, 2013

The Curation Economy

›
In an October 7th article in The Huffington Post blog section , Steve Rosenbaum discusses the development of a so-called "Curation Econ...
Sunday, October 6, 2013

CPIC publishes guidelines for IFNL3 (IL28B) and peginterferon alpha based regimens

›
Guidelines regarding the use of IFNL3 (formerly known as IL28B ) genotypes in peginterferon alpha based therapies have been accepted for pu...
Monday, September 23, 2013

CYP2D6 genotype and tamoxifen response: meta-analysis of heterogeneous population

›
Tamoxifen treatment results in substantial inter-individual variability of outcome, possibly due to genetic variability in CYP2D6. ...
Tuesday, September 17, 2013

New EGFR VIP Summary Published in PG&G

›
The epidermal growth factor receptor ( EGFR ) is involved in the growth of many epithelial malignancies, such as non-small-cell lung cancer ...